The biopharmcatalyst biotech stock ipo calendar gives a brief rundown of upcoming biotech initial public offerings. Dec 28, 2021 · in other vor biopharma news, major shareholder ventures vi l.p. Dec 01, 2021 · the investor relations website contains information about vor biopharma's business for stockholders, potential investors, and financial analysts. 5am sold 330,706 shares of vor biopharma stock in a transaction dated tuesday, november 16th. Jan 08, 2022 · vor biopharma inc (vor) shares closed today at 1.1% above its 52 week low of $10.46, giving the company a market cap of $394m.
The biopharmcatalyst biotech stock ipo calendar gives a brief rundown of upcoming biotech initial public offerings.
The biopharmcatalyst biotech stock ipo calendar gives a brief rundown of upcoming biotech initial public offerings. Dec 28, 2021 · in other vor biopharma news, major shareholder ventures vi l.p. 5am sold 330,706 shares of vor biopharma stock in a transaction dated tuesday, november 16th. The firm has a $38 price target and (193% upside). Jan 08, 2022 · vor biopharma inc (vor) shares closed today at 1.1% above its 52 week low of $10.46, giving the company a market cap of $394m. Dec 01, 2021 · the investor relations website contains information about vor biopharma's business for stockholders, potential investors, and financial analysts. Wed, jan 12, 2022, 4:00pm est We initially share this idea in october 2018 and the stock. The stock was sold at an average price of $15.30, for a total transaction of $5,059,801.80.
The firm has a $38 price target and (193% upside). The biopharmcatalyst biotech stock ipo calendar gives a brief rundown of upcoming biotech initial public offerings. Dec 01, 2021 · the investor relations website contains information about vor biopharma's business for stockholders, potential investors, and financial analysts. We initially share this idea in october 2018 and the stock. Jan 08, 2022 · vor biopharma inc (vor) shares closed today at 1.1% above its 52 week low of $10.46, giving the company a market cap of $394m.
Dec 28, 2021 · in other vor biopharma news, major shareholder ventures vi l.p.
The firm has a $38 price target and (193% upside). Jan 08, 2022 · vor biopharma inc (vor) shares closed today at 1.1% above its 52 week low of $10.46, giving the company a market cap of $394m. Dec 01, 2021 · the investor relations website contains information about vor biopharma's business for stockholders, potential investors, and financial analysts. We initially share this idea in october 2018 and the stock. The biopharmcatalyst biotech stock ipo calendar gives a brief rundown of upcoming biotech initial public offerings. 5am sold 330,706 shares of vor biopharma stock in a transaction dated tuesday, november 16th. The stock was sold at an average price of $15.30, for a total transaction of $5,059,801.80. Dec 28, 2021 · in other vor biopharma news, major shareholder ventures vi l.p. Wed, jan 12, 2022, 4:00pm est
The stock was sold at an average price of $15.30, for a total transaction of $5,059,801.80. 5am sold 330,706 shares of vor biopharma stock in a transaction dated tuesday, november 16th. The firm has a $38 price target and (193% upside). Dec 28, 2021 · in other vor biopharma news, major shareholder ventures vi l.p. Wed, jan 12, 2022, 4:00pm est
The stock was sold at an average price of $15.30, for a total transaction of $5,059,801.80.
Dec 01, 2021 · the investor relations website contains information about vor biopharma's business for stockholders, potential investors, and financial analysts. The biopharmcatalyst biotech stock ipo calendar gives a brief rundown of upcoming biotech initial public offerings. Wed, jan 12, 2022, 4:00pm est Dec 28, 2021 · in other vor biopharma news, major shareholder ventures vi l.p. Jan 08, 2022 · vor biopharma inc (vor) shares closed today at 1.1% above its 52 week low of $10.46, giving the company a market cap of $394m. The stock was sold at an average price of $15.30, for a total transaction of $5,059,801.80. 5am sold 330,706 shares of vor biopharma stock in a transaction dated tuesday, november 16th. The firm has a $38 price target and (193% upside). We initially share this idea in october 2018 and the stock.
Vor Biopharma Stock Price - Vor Biopharma Inc Vor Stock Price Quote News Stock Analysis / The biopharmcatalyst biotech stock ipo calendar gives a brief rundown of upcoming biotech initial public offerings.. The firm has a $38 price target and (193% upside). We initially share this idea in october 2018 and the stock. The biopharmcatalyst biotech stock ipo calendar gives a brief rundown of upcoming biotech initial public offerings. Jan 08, 2022 · vor biopharma inc (vor) shares closed today at 1.1% above its 52 week low of $10.46, giving the company a market cap of $394m. Dec 28, 2021 · in other vor biopharma news, major shareholder ventures vi l.p.